Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study.

Autor: Cantini L; Clinical Oncology, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria delle Marche, Ancona, Italy.; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands.; Labcorp Drug Development Inc, Princeton, NJ, USA., Paoloni F; Clinical Oncology, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria delle Marche, Ancona, Italy., Pecci F; Clinical Oncology, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria delle Marche, Ancona, Italy., Spagnolo F; Medical Oncology Unit 2, Istituto di ricovero e cura a carattere scientific (IRCCS) Ospedale Policlinico San Martino, Genova, Italy., Genova C; Academic Medical Oncology Unit, Istituto di ricovero e cura a carattere scientific (IRCCS) Ospedale Policlinico San Martino, Genoa, Italy.; Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genoa, Italy., Tanda ET; Medical Oncology Unit 2, Istituto di ricovero e cura a carattere scientific (IRCCS) Ospedale Policlinico San Martino, Genova, Italy., Aerts S; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands., Rebuzzi SE; Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genoa, Italy.; Medical Oncology Unit, Ospedale San Paolo, Savona, Italy., Fornarini G; Medical Oncology Unit 1, Istituto di ricovero e cura a carattere scientific (IRCCS) Ospedale Policlinico San Martino, Genoa, Italy., Zoratto F; UOC Oncologia, Ospedale Santa Maria Goretti, Latina, Italy., Fancelli S; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.; Clinical Oncology Unit, Careggi University Hospital, Florence, Italy., Lupi A; Clinical Oncology, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria delle Marche, Ancona, Italy., Della Corte CM; Department of Precision Medicine, University of Campania, Italy., Parisi A; Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy., Bennati C; S Maria delle Croci Hospital, AUSL della Romagna, Ravenna, Italy., Ortega C; Oncology, Asl Cn2, Ospedale Michele e Pietro Ferrero, Verduno, Italy., Atzori F; Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy., Piovano PL; Oncology Unit, Azienda Ospedaliera 'SS. Antonio e Biagio e C. Arrigo', Alessandria, Italy., Orciuolo C; Istituto di ricovero e cura a carattere scientific (IRCCS), National Cancer Institute Regina Elena, Rome, Italy., De Tursi M; Department of Innovative Technologies in Medicine and Dentistry, University G. D'Annunzio, Chieti-Pescara, Italy., Ghidini M; Oncology Unit, Fondazione Istituto di ricovero e cura a carattere scientific (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy., Botticelli A; Medical Oncology Unit A, Policlinico Umberto I, Radiological, Oncological, Pathological Sciences Department, Sapienza University of Rome, Italy., Scagnoli S; Medical Oncology Unit B, Policlinico Umberto I, Rome, Italy., Belluomini L; Section of Oncology, Department of Medicine, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy., Leporati R; Medical Oncology, Fondazione Istituto di ricovero e cura a carattere scientific (IRCCS) Istituto Nazionale dei Tumori, Milano, Italy., Veccia A; Medical Oncology, Santa Chiara Hospital, Largo Medaglie d'Oro 1, Trento, Italy., Di Giacomo AM; Center for Immuno-Oncology, University of Siena, University Hospital of Siena, Siena, Italy., Festino L; Melanoma Unit, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori Istituto di ricovero e cura a carattere scientific (IRCCS) Fondazione 'G. Pascale', Naples, Italy., Cortinovis D; SC Oncologia Medica ASST H S Gerardo, Monza, Italy., Acquati M; SC Oncologia Medica ASST H S Gerardo, Monza, Italy., Filetti M; Phase 1 Unit, Fondazione Policlinico Universitario Agostino Gemelli, Istituto di ricovero e cura a carattere scientific (IRCCS), Rome, Italy., Giusti R; Medical Oncology Unit, Sant'Andrea Hospital of Rome, Italy., Tucci M; Medical Oncology Unit, Department of Interdisciplinary Medicine, University of Bari Aldo Moro, Italy., Sergi MC; Medical Oncology Unit, Department of Interdisciplinary Medicine, University of Bari Aldo Moro, Italy., Garutti M; CRO Aviano, National Cancer Institute, Istituto di ricovero e cura a carattere scientific (IRCCS), Aviano, Italy., Puglisi F; CRO Aviano, National Cancer Institute, Istituto di ricovero e cura a carattere scientific (IRCCS), Aviano, Italy.; Department of Medicine (DAME), University of Udine, Udine, Italy., Manglaviti S; Thoracic Unit, Medical Oncology Department 1, Fondazione Istituto di ricovero e cura a carattere scientific (IRCCS) Istituto Nazionale dei Tumori di Milano, Italy., Citarella F; Department of Medical Oncology, Campus Bio-Medico University, Rome, Italy., Santoni M; Oncology Unit, Macerata Hospital, Macerata, Italy., Rijavec E; Medical Oncology Unit, Ospedale di Circolo e Fondazione Macchi, asst Settelaghi, Varese, Italy., Lo Russo G; Thoracic Unit, Medical Oncology Department 1, Fondazione Istituto di ricovero e cura a carattere scientific (IRCCS) Istituto Nazionale dei Tumori di Milano, Italy., Santini D; UOC Oncologia Medica Territoriale, Sapienza Università, Polo Pontino, Rome, Italy., Addeo A; Oncology Department, University Hospital Geneva, Geneva, Switzerland., Antonuzzo L; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.; Clinical Oncology Unit, and Medical Oncology Unit, Careggi University Hospital, Florence, Italy., Indini A; Medical Oncology Unit, Ospedale di Circolo e Fondazione Macchi, asst Settelaghi, Varese, Italy., Rocchi MBL; Biomolecular Sciences Department, University of Urbino, Urbino, Italy., Cortellini A; Division of Cancer, Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK., Grossi F; Medical Oncology Unit, Ospedale di Circolo e Fondazione Macchi, asst Settelaghi, University of insubria, Varese, Italy., Ascierto PA; Melanoma Unit, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori Istituto di ricovero e cura a carattere scientific (IRCCS) Fondazione 'G. Pascale', Naples, Italy., Aerts JGJV; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands., Berardi R; Clinical Oncology, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria delle Marche, Ancona, Italy.

Publikováno v: Journal of the National Cancer Institute [J Natl Cancer Inst] 2023 Jul 06; Vol. 115 (7), pp. 796-804.

Be-TeaM: An Italian real-world observational study on second-line therapy for EGFR-mutated NSCLC patients.

Autor: Reale ML; Department of Oncology, University of Turin, AOU San Luigi Gonzaga, Regione Gonzole, 10, 10043, Orbassano, TO, Italy. Electronic address: realemarialucia@gmail.com., Chiari R; UOC Oncology, Ospedali Riuniti Padova Sud-AULSS6 Euganea, Via Albere, 30, Monselice, PD, Italy(1). Electronic address: ritachiar@gmail.com., Tiseo M; Department of Medicine and Surgery, University of Parma and Medical Oncology Unit, Azienda Ospedaliero-Universitaria, Viale Antonio Gramsci, 14, 43126, Parma, Italy. Electronic address: mtiseo@ao.pr.it., Vitiello F; U.O.S.D. DH Pneumoncologico A.O. dei Colli - Monaldi, Via Leonardo Bianchi, 80131, Napoli, Italy. Electronic address: fabianavitiello@libero.it., Barbieri F; Dipartimento Oncologia ed Ematologia, AOU Policlinico, Largo del Pozzo, 71, 41125, Modena, Italy. Electronic address: barbieri.fausto@aou.mo.it., Cortinovis D; UO Oncologia Medica, ASST Ospedale San Gerardo, Via G. B. Pergolesi, 33, 20900, Monza, MB, Italy. Electronic address: d.cortinovis@hsgerardo.org., Ceresoli GL; Unità di Oncologia Toracica e Urologica, Humanitas Gavazzeni, Via Mauro Gavazzeni, 21, 24125, Bergamo, Italy. Electronic address: giovanni_luca.ceresoli@gavazzeni.it., Finocchiaro G; U.O Oncologia Medica ed Ematologia, Humanitas Cancer Center, Istituto Clinico Humanitas-IRCCS, Via Alessandro Manzoni, 56, 20089, Rozzano, MI, Italy. Electronic address: giovanna.finocchiaro@cancercenter.humanitas.it., Romano GD; Oncologia, Ospedale Vito Fazzi, Piazza Filippo Muratore, 1, 73100, Lecce, Italy. Electronic address: giampieroromano@tiscali.it., Piovano PL; SC Oncologia, ASO SS Antonio e Biagio e C Arrigo, Via Venezia, 16, 15121, Alessandria, Italy. Electronic address: plpiovano@ospedale.al.it., Del Conte A; S.C. Oncologia Medica e dei Tumori Immunocorrelati (OMTI), Centro di Riferimento Oncologico (CRO) - IRCCS, Via Franco Gallini, 2, 33081, Aviano, PN, Italy. Electronic address: alessandro.delconte@cro.it., Borra G; Dipartimento Medico Specialistico ed Oncologico, AOU Maggiore della Carità, corso Mazzini 18, Novara, Italy. Electronic address: gloria.borra@libero.it., Verderame F; U.O Oncologia Medica, AO Riuniti Villa Sofia - Cervello, Via Trabucco 180, 90146, Palermo, Italy. Electronic address: f.verderame@villasofia.it., Scotti V; Unità di Radioterapia Oncologica - Dipartimento di Oncologia, Azienda Ospedaliero-universitaria Careggi, Largo G. Alessandro Brambilla, 3, 50134, Florence, Italy. Electronic address: vieri.scotti@unifi.it., Nonnis D; Oncologia Medica, ASST Spedali Civili, Piazzale Spedali Civili, 1, 25123, Brescia, Italy. Electronic address: daninonnis@yahoo.it., Galetta D; SSD Oncologia Medica Patologia Toracica IRCCS Oncologico Giovanni Paolo II, Viale Orazio Flacco, 65, 70124, Bari, Italy. Electronic address: galetta@teseo.it., Sergi C; U.O.C Oncologia Medica, AO di rilievo Nazionale, ARNAS Garibaldi-Nesima, Via Palermo, 636, Catania, Italy. Electronic address: consergi1974@gmail.com., Migliorino MR; U.O.C Pneumologia Oncologica, AO S. Camillo Forlanini, Circonvallazione Gianicolense, 87, 00152, Roma, Italy. Electronic address: ritamigliorino@tiscali.it., Tonini G; Dipartimento di Oncologia, Università Campus Bio-Medico, Via Alvaro del Portillo 200, 00128, Roma, Italy. Electronic address: G.Tonini@unicampus.it., Cecere F; U.O. Oncologia Medica, Istituto Tumori Regina Elena, Via Elio Chianesi, 53, 00128, Roma, Italy. Electronic address: fabianacecere@gmail.com., Berardi R; SOD Clinica Oncologica, AOU Ospedali Riuniti, Via Conca, 71, 60126, Ancona, Italy. Electronic address: r.berardi@univpm.it., Pino MS; U.O. Oncologia Medica, Ospedale S. Maria Annunziata, Via Antella, 58, 50012, Ponte a Niccheri, Bagno a Ripoli, FI, Italy. Electronic address: mariasimona.pino@uslcentro.toscana.it., Martelli O; U.O Oncologia Medica, Azienda Ospedaliera S Giovanni-Addolorata, Via dell'Amba Aradam 8, 00184, Roma, Italy. Electronic address: omartelli@hsangiovanni.roma.it., Gelibter A; U.O Oncologia Medica, Policlinico Umberto I, Via del Policlinico 155, Roma, Italy. Electronic address: agelibter@yahoo.it., Carta A; U.O Oncologia Medica, Ospedale A. Businco, Via Edward Jenner, 1, 09121, Cagliari, Italy. Electronic address: deventer1975@gmail.com., Vattemi E; U.O Oncologia Medica, Ospedale Regionale, Via Lorenz Böhler, 5, 39100, Bolzano, Italy. Electronic address: EMANUELA.VATTEMI@sabes.it., Pagano M; Azienda Unità Sanitaria Locale-IRCCS, Via Giovanni Amendola, 2, 42122, Reggio Emilia, Italy. Electronic address: pagano.maria@ausl.re.it., Zullo A; MediNeos, Viale Virgilio, 54/U, 41123, Modena, Italy. Electronic address: a.zullo@medineos.com., Ferrari S; AstraZeneca S.p.A., Via Ludovico il Moro, 6/C, 20080, Basiglio, MI, Italy. Electronic address: Silvia.Ferrari@astrazeneca.com., Rossi A; Oncology Unit, Fondazione IRCCS Casa Sollievo della Sofferenza, Viale Cappuccini, 1, 71013, San Giovanni Rotondo, FG, Italy. Electronic address: arossi_it@yahoo.it., Novello S; Department of Oncology, University of Turin, AOU San Luigi Gonzaga, Regione Gonzole, 10, 10043, Orbassano, TO, Italy. Electronic address: silvia.novello@unito.it.

Publikováno v: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2020 Feb; Vol. 140, pp. 71-79. Date of Electronic Publication: 2019 Dec 16.

BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients: Results from a multicenter Italian observational study.

Autor: Vavalà T; Department of Oncology, University of Torino AOU San Luigi, Regione Gonzole 10, 10043 Orbassano (TO), Italy., Follador A; Department of Oncology, University Hospital of Udine, Piazzale S. Maria della Misericordia 15, 33100 Udine, Italy., Tiseo M; Medical Oncology Unit, University Hospital of Parma, via Gramsci, 14, 43126 Parma, Italy., Galetta D; Medical Oncology Unit, Clinical Cancer Center Giovanni Paolo II, viale Orazio Flacco, 65, 70124 Bari, Italy., Morabito A; Thoracic Medical Oncology, National Cancer Institute, Fondazione 'G.Pascale', via Mariano Semmola 80131, Napoli, Italy., Di Maio M; Clinical Trials Unit, National Cancer Institute, Fondazione 'G.Pascale', via Mariano Semmola, 80131 Napoli, Italy., Martelli O; Medical Oncology, S.Giovanni-Addolorata Hospital, via di S. Stefano Rotondo 5a, 00184 Roma, Italy., Caffo O; Medical Oncology Unit, Santa Chiara Hospital, Largo Medaglie D'oro 9, 38122 Trento, Italy., Piovano PL; Medical Oncology Unit, AO SS. Antonio Biagio e Cesare Arrigo, via S. Pio V 5, Alessandria, Italy., Cortinovis D; Medical Oncology Unit, AOU San Gerardo, via Giambattista Pergolesi 33, 20900 Monza, Italy., Zilembo N; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, via Giacomo Venezian 1, Milano, Italy., Casartelli C; Medical Oncology Unit, Valduce Hospital, via Dante Alighieri 11, 22100 Como, Italy., Banna GL; Division of Medical Oncology, AO Cannizzaro Hospital, via Messina 829, 95126 Catania, Italy., Ardizzoia A; Medical Oncology Unit, A.Manzoni Hospital via dell'Eremo 9/11, 23900 Lecco, Italy., Barzelloni ML; AOU San Giovanni di Dio e Ruggi d' Aragona c/o P.O. G. da Procida, largo Città di Ippocrate, 84131 Salerno, Italy., Bearz A; Department of Medical Oncology, National Institute for Cancer Research, via Franco Gallini 2, Aviano (PN), Italy., Genestreti G; Department of Medical Oncology, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), via Piero Maroncelli 40, 47014 Meldola, Italy., Mucciarini C; Department of Oncological Medicine, Ramazzini Hospital, via Guido Molinari 2, 41012 Carpi (MO), Italy., Filipazzi V; UOC Medical Oncology, AO Luigi Sacco, via Giovanni Battista Grassi 74, 20157 Milano,Italy., Menis J; Department of Oncology, University Hospital of Udine, Piazzale S. Maria della Misericordia 15, 33100 Udine, Italy., Rizzo E; EORTC Headquarters, Avenue E. Mounier 83, 1200 Bruxelles, Belgium., Barbieri F; Department of Oncology and Hemathology, AOU of Modena, viale del pozzo 71, Modena, Italy., Rijavec E; Lung Cancer Unit, IRCCS AOU San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Largo R. Benzi 10, 16132 Genova, Italy., Cecere F; Medical Oncology Unit, University Hospital Careggi, Largo Brambilla 3, 50134 Firenze, Italy., Bria E; Medical Oncology, University of Verona, Azienda Ospedaliera Universitaria Integrata di Verona, P.zza L. A. Scuro 10, 37134 Verona, Italy., Spitaleri G; Division of Thoracic Oncology, European Institute of Oncology, via Ripamonti 435, 20141 Milano, Italy., Rossi A; Division of Medical Oncology, S.G. Moscati Hospital, Contrada Amoretta Avellino, Italy., Novello S; Department of Oncology, University of Torino AOU San Luigi, Regione Gonzole 10, 10043 Orbassano (TO), Italy. Electronic address: silvia.novello@unito.it.

Publikováno v: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2016 May; Vol. 95, pp. 73-81. Date of Electronic Publication: 2016 Feb 26.

Seizures during concomitant treatment with theophylline and ranitidine: a case report.

Autor: Murialdo G; Istituto Scientifico di Medicina Interna, Università degli Studi di Genova., Piovano PL, Costelli P, Fonzi S, Barberis A, Ghia M

Publikováno v: Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna [Ann Ital Med Int] 1990 Oct-Dec; Vol. 5 (4 Pt 1), pp. 413.